Unintentional treatment interruptions in diabetic retinopathy patients, especially those with proliferative disease, managed with antivascular endothelial growth factor (anti-VEGF) therapy alone can result in irreversible blindness, as shown in a recent study.
In patients with acute central retinal vein occlusion, a history of systemic hypertension and presenting with worse visual acuity and a relative afferent pupillary defect predict the development of neovascular glaucoma, a retrospective study has shown.
A UK study has recently found that while adalimumab is clinically effective in uveitis associated with juvenile idiopathic arthritis (JIA), its cost-effectiveness compared with methotrexate alone in the UK setting is not demonstrated.
Higher adherence to the Mediterranean Diet (MedDiet) results in a 41-percent reduced risk of incident advanced age-related macular degeneration (AMD), according to pooled data from the Rotterdam Study I (RS-I) and Alienor* Study.
Retinal microvascular signs, while relatively rare, may reflect microvascular pathology in the brain, which potentially leads to dementia and cognitive impairment, according to a recent cross-sectional analysis of the Atherosclerosis Risk in Communities cohort.
Using smartphone cameras for ophthalmic examination may result in variabilities in the objective quantification of conjunctival redness, highlighting the importance of camera calibration, a recent study has found.
It appears that attending cram school for ≥2 h/d increases the risk of children’s incident myopia, which may be caused by greater near visual activity or reduced time outdoors, suggests a recent Taiwan study.
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.